Tscan Therapeutics Inc (TCRX) — Financial Flexibility Index
Tscan Therapeutics Inc (TCRX) has a Financial Flexibility Index of -0.23x as of March 2026. Free cash flow of $-24.21 Million (operating CF $-24.28 Million minus capex $70.00K) represents 0% of total liabilities ($105.07 Million). Also explore how fast is Tscan Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tscan Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Tscan Therapeutics Inc across 7 annual periods. Check how strategically is Tscan Therapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Tscan Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Tscan Therapeutics Inc. For the full company profile including market capitalisation, see Tscan Therapeutics Inc (TCRX) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.24x | $-130.91 Million | $-135.32 Million | $105.67 Million | ▼ -50.7% |
| 2024 | -0.82x | $-107.00 Million | $-110.82 Million | $130.15 Million | ▼ -71.3% |
| 2023 | -0.48x | $-58.21 Million | $-61.36 Million | $121.28 Million | ▲ +23.2% |
| 2022 | -0.62x | $-62.28 Million | $-66.50 Million | $99.66 Million | ▲ +55.9% |
| 2021 | -1.42x | $-38.74 Million | $-48.68 Million | $27.33 Million | ▼ -10855.9% |
| 2020 | 0.01x | $1.22 Million | $-3.02 Million | $92.20 Million | ▲ +100.8% |
| 2019 | -1.65x | $-11.28 Million | $-12.52 Million | $6.84 Million | — |